{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:21:04Z","timestamp":1791418864573,"version":"4.3.3"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.revmed.2012.12.003","type":"journal-article","created":{"date-parts":[[2013,1,9]],"date-time":"2013-01-09T19:48:26Z","timestamp":1357760906000},"page":"279-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Corticoth\u00e9rapie syst\u00e9mique\u00a0: les mesures d\u2019accompagnement"],"prefix":"10.1016","volume":"34","author":[{"given":"L.","family":"Sailler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pugnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Arlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2012.12.003_bib0005","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.revmed.2007.06.002","article-title":"Histoire naturelle de la lipodystrophie cervicofaciale cortico-induite\u00a0: suivi prospectif d\u2019une cohorte de 37\u00a0patients","volume":"28","author":"Fardet","year":"2007","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2012.12.003_bib0010","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2133.2007.07950.x","article-title":"Corticosteroid-induced clinical adverse events: frequency, risk factors and patient's opinion","volume":"157","author":"Fardet","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2012.12.003_bib0015","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/rheumatology\/kem062","article-title":"Corticosteroid-induced lipodystrophy is associated with features of the metabolic syndrome","volume":"46","author":"Fardet","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2012.12.003_bib0020","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jaad.2007.04.018","article-title":"Incidence and risk factors for corticosteroid-induced lipodystrophy: a prospective study","volume":"57","author":"Fardet","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2012.12.003_bib0025","doi-asserted-by":"crossref","first-page":"e4928","DOI":"10.1136\/bmj.e4928","article-title":"Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing's syndrome: cohort study","volume":"345","author":"Fardet","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.revmed.2012.12.003_bib0030","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.revmed.2006.12.013","article-title":"Corticoth\u00e9rapie syst\u00e9mique et alimentation\u00a0: suivi des recommandations di\u00e9t\u00e9tiques et relation entre apports alimentaires et apparition d\u2019une lipodystrophie","volume":"28","author":"Fardet","year":"2007","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2012.12.003_bib0035","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1210\/jcem-51-3-561","article-title":"Prednisolone disposition in cushingoid and noncushingoid kidney transplant patients","volume":"51","author":"Gambertoglio","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2012.12.003_bib0040","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/ki.1985.31","article-title":"Prednisolone pharmacokinetics in cushingoid and non-cushingoid kidney transplant patients","volume":"27","author":"Bergrem","year":"1985","journal-title":"Kidney Int"},{"key":"10.1016\/j.revmed.2012.12.003_bib0045","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1210\/jcem-38-3-407","article-title":"Decreased clearance of prednisolone, a factor in the development of corticosteroid side effects","volume":"38","author":"Kozower","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2012.12.003_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-07-0606","article-title":"Mechanisms of glucocorticoid-induced myopathy","volume":"197","author":"Schakman","year":"2008","journal-title":"J Endocrinol"},{"key":"10.1016\/j.revmed.2012.12.003_bib0055","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1590\/S0066-782X2009001000014","article-title":"Exercise prevents cardiometabolic alterations induced by chronic use of glucocorticoids","volume":"93","author":"Pinheiro","year":"2009","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.revmed.2012.12.003_bib0060","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00005768-199804000-00003","article-title":"Resistance exercise prevents glucocorticoid-induced myopathy in heart transplant recipients","volume":"30","author":"Braith","year":"1998","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.revmed.2012.12.003_bib0065","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1210\/jcem-61-1-83","article-title":"Evidence that prednisone-induced myopathy is reversed by physical training","volume":"61","author":"Horber","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2012.12.003_bib0070","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00008483-199703000-00002","article-title":"Glucocorticoid-induced muscle atrophy. The role of exercise in treatment and prevention","volume":"17","author":"LaPier","year":"1997","journal-title":"J Cardiopulm Rehabil"},{"key":"10.1016\/j.revmed.2012.12.003_bib0075","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2119\/molmed.2010.00016","article-title":"A longitudinal, integrated, clinical, histological and mRNA profiling study of resistance exercise in myositis","volume":"16","author":"Nader","year":"2010","journal-title":"Mol Med"},{"key":"10.1016\/j.revmed.2012.12.003_bib0080","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/rheumatology\/38.7.608","article-title":"Safety of a home exercise programme in patients with polymyositis and dermatomyositis: a pilot study","volume":"38","author":"Alexanderson","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2012.12.003_bib0085","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/art.22687","article-title":"Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: six-month, double-blind, randomized, placebo-controlled trial","volume":"57","author":"Chung","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"Suppl.\u00a010","key":"10.1016\/j.revmed.2012.12.003_bib0090","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00005768-199810001-00005","article-title":"Exercise training in patients with CHF and heart transplant recipients","author":"Braith","year":"1998","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.revmed.2012.12.003_bib0095","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.revmed.2008.04.001","article-title":"Long-term systemic corticosteroid-therapy associated measures: description of the French internal medicine physicians\u2019 practices","volume":"29","author":"Fardet","year":"2008","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2012.12.003_bib0100","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjmed.2011.05.024","article-title":"Drug-induced hypertension: an unappreciated cause of secondary hypertension","volume":"125","author":"Grossman","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2012.12.003_bib0105","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ecl.2011.01.010","article-title":"How do glucocorticoids cause hypertension: role of nitric oxide deficiency, oxidative stress, and eicosanoids","volume":"40","author":"Ong","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.revmed.2012.12.003_bib0110","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1440-1681.2008.04900.x","article-title":"Reactive oxygen species and glucocorticoid-induced hypertension","volume":"35","author":"Ong","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.revmed.2012.12.003_bib0115","doi-asserted-by":"crossref","first-page":"b4567","DOI":"10.1136\/bmj.b4567","article-title":"Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies","volume":"339","author":"Strazzullo","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.revmed.2012.12.003_bib0120","first-page":"CD004022","article-title":"Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride","volume":"11","author":"Graudal","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.revmed.2012.12.003_bib0125","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ajh.2011.115","article-title":"Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review)","volume":"24","author":"Taylor","year":"2011","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.revmed.2012.12.003_bib0130","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.3399\/bjgp11X578034","article-title":"Predictors of incident atrial fibrillation and influence of medications: a retrospective case-control study","volume":"61","author":"Hodgkinson","year":"2011","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.revmed.2012.12.003_bib0135","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1001\/archinternmed.2009.297","article-title":"Glucocorticoid use and risk of atrial fibrillation or flutter: a population-based, case-control study","volume":"169","author":"Christiansen","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.revmed.2012.12.003_bib0140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archinte.1994.00420010131015","article-title":"Glucocorticoids and the risk for initiation of hypoglycemic therapy","volume":"154","author":"Gurwitz","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.revmed.2012.12.003_bib0145","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.2337\/dc06-1499","article-title":"Risk of diabetes associated with prescribed glucocorticoids in a large population","volume":"29","author":"Gulliford","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.revmed.2012.12.003_bib0150","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1530\/EJE-12-0041","article-title":"Glucocorticoid treatment and impaired mood, memory and metabolism in people with diabetes: the Edinburgh Type 2\u00a0Diabetes Study","volume":"166","author":"Reynolds","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.revmed.2012.12.003_bib0155","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3949\/ccjm.78a.10180","article-title":"Glucocorticoid-induced diabetes and adrenal suppression: how to detect and manage them","volume":"78","author":"Lansang","year":"2011","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.revmed.2012.12.003_bib0160","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/pds.2350","article-title":"Factors associated with the initiation of proton pump inhibitors in corticosteroid users","volume":"21","author":"Munson","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.revmed.2012.12.003_bib0165","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM198307073090105","article-title":"Association of adrenocorticosteroid therapy and peptic-ulcer disease","volume":"309","author":"Messer","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2012.12.003_bib0170","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2796.1994.tb00855.x","article-title":"Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy","volume":"236","author":"Conn","year":"1994","journal-title":"J Intern Med"},{"key":"10.1016\/j.revmed.2012.12.003_bib0175","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1046\/j.1365-2036.2002.01279.x","article-title":"The potential risk factors leading to peptic ulcer formation in autoimmune disease patients receiving corticosteroid treatment","volume":"16","author":"Luo","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.revmed.2012.12.003_bib0180","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.pmrj.2010.09.010","article-title":"Critical gastrointestinal bleeding at an inpatient rehabilitation center: incidence, risk factors, and the role of gastrointestinal prophylaxis","volume":"2","author":"Faulk","year":"2010","journal-title":"PM R"},{"key":"10.1016\/j.revmed.2012.12.003_bib0185","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.3109\/00365521.2010.510567","article-title":"Impact of aspirin NSAIDs, warfarin, corticosteroids and SSRIs on the site and outcome of non-variceal upper and lower gastrointestinal bleeding","volume":"45","author":"Ahsberg","year":"2010","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.revmed.2012.12.003_bib0190","unstructured":"Haute Autorit\u00e9 de sant\u00e9. Commission de transparence. R\u00e9\u00e9valuation des inhibiteurs de la pompe \u00e0 protons chez l\u2019adulte. 2009."}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866312011800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866312011800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:31:08Z","timestamp":1759336268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866312011800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0248866312011800"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2012.12.003","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Corticoth\u00e9rapie syst\u00e9mique\u00a0: les mesures d\u2019accompagnement","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2012.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}